Focus: Sofie is a radiopharmaceutical company specializing in PET imaging probes and radiochemical synthesis for oncology, rare diseases, and infectious disease applications. The company operates a portfolio of FDA-approved diagnostic agents and advanced pipeline programs targeting high-value oncology indications.
Profile data last refreshed 6h ago · AI intelligence enriched 3w ago
Hot — 78 jobs added in 30d
Net +62 (78 new, 16 removed). Aggressive expansion phase.
Sofie presents a differentiated career opportunity in a specialized therapeutic area with clinical momentum, but limited transparency around financials and hiring scale may signal a smaller, privately-held operation with less organizational depth.
Automated analysis based on publicly available data (FDA, SEC, ClinicalTrials.gov). May be incomplete or delayed. This score does not reflect insider knowledge and should not be used as the sole basis for investment or employment decisions.
Cornerstone diagnostic radiopharmaceutical for PET imaging; multiple ANDA entries indicate manufacturing scale across multiple production sites.
Help build intelligence for Sofie
No one has shared interview or compensation data for this company yet. You'll earn 7 days of Pro access.
The information on this page is for informational purposes only and should not be used as a substitute for professional medical advice. Drug information is sourced from FDA, DailyMed, and other government databases. Adverse event data from FAERS does not establish causation. Always consult a healthcare professional for medical decisions.
Generated by Claude from Sofie's SEC filings, pipeline programs, hiring velocity, FDA actions, and WARN data. Inference, not editorial — verify before quoting.
Established agent for cardiac PET imaging; retained in myocardial cells after intravenous administration for diagnostic assessment.
FDA-approved diagnostic agent with selective skeletal accumulation; utility in bone imaging across multiple clinical applications.
3 discontinued, 3 duplicate formulations not shown
Upgrade to Pro to access AI interview prep brief and other premium pharma intelligence.
Upgrade to Pro — $25/moBased on last 4 crawl cycles